MS- Ocrelizumab DI Flashcards
Ocrelizumab brand name
Ocrevus
Ocrevus indications
CIS, RRMS, active SPMS, PPMS
Ocrevus MoA
Binds to CD20 on surface B cells and depletes them from circulation
Ocrevus dosing
300mg IV day 1, then 300mg IV 2 weeks later
Future doses of 600mg are administered once every 6 months after that
Ocrevus ADEs
Infusion reactions, UTIs, URTIs, HA, nausea
How to handle infusion site reactions from Ocrevus
Premedicate with steroids (methylprednisolone 100mg IV 30 minutes before), APAP, or antihistamines (diphenhydramine 30-60 minutes prior)
Ocrevus CIs
History of life-threatening infusion reaction or any component of the medication, active HBV
Ocrevus warnings/precautions
HBV reactivation, herpes infections, infections, breast cancer/malignancy
First drug to show positive results for PPMS
Ocrevus!